HASEENA MIRZA: Open Payments
NPI 1750552444 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,105 in 45 payments from 16 companies in 2025. Trend: 2023 $597 · 2024 $843 · 2025 $1,105
Food & beverage: $1,105
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $196 |
| Novo Nordisk Inc | 12 | $183 |
| Corcept Therapeutics | 3 | $166 |
| Lilly USA, LLC | 4 | $89 |
| Insulet Corporation | 2 | $86 |
| Dexcom, Inc. | 3 | $85 |
| Abbott Laboratories | 2 | $59 |
| Mannkind Corporation | 3 | $55 |
| Alvogen Inc | 1 | $29 |
| Sequel Med Tech, LLC | 1 | $28 |
Products named: Korlym, Ozempic, TEPEZZA, Omnipod, Dexcom G6 Transmitter, EVENITY, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across CA — which companies pay providers there.
